玻璃體手術器材市場－全球產業規模、佔有率、趨勢、機會及預測（依產品、應用、最終用途、地區及競爭格局分類，2021-2031年）

全球玻璃體切除設備市場預計將從 2025 年的 17.2 億美元成長到 2031 年的 24.8 億美元，複合年成長率為 6.29%。

該市場主要包括用於治療視網膜疾病（例如黃斑裂孔和視網膜剝離）的玻璃體切除專用手術器械和系統。推動市場成長的關鍵因素包括眼科疾病率的上升和全球人口老化。糖尿病發生率的不斷攀升是推動這項需求的關鍵因素，因為糖尿病會顯著增加糖尿病視網膜病變的風險。正如國際糖尿病聯盟（IDF）所指出的，到2024年，全球將有約5.89億成年人患有糖尿病，這將形成一個龐大的患者群體，需要有效的玻璃體視網膜治療，並持續推動對這些手術器械的需求。

然而，阻礙市場成長的主要障礙是先進玻璃體切除系統和手術本身的高成本。這一經濟障礙限制了醫療預算有限的發展中地區獲得基本眼科護理的機會。此外，這些地區熟練的視網膜外科醫生短缺，加劇了及時治療的難度，對玻璃體視網膜技術的廣泛應用構成了重大阻礙。

市場促進因素

玻璃體手術器械的技術創新正透過提高手術精確度和改善患者預後，顯著推動市場成長。現代玻璃體手術系統整合了許多多功能，例如更高的切割速度、更佳的流體控制以及更小規格的器械，這些功能共同減少了視網膜牽拉，並最大限度地降低了術後併發症。隨著醫院向更安全、更有效率的平台轉型，這項創新週期持續推動設備更新和高階耗材的需求。主要產業參與者的財務表現也印證了市場對這些先進技術的強勁支持。例如，愛爾康公司在2024年2月發布的「2023年第四季及全年業績」報告中指出，其手術耗材季度淨銷售額為6.88億美元，並將這一成長歸功於對玻璃體視網膜產品的需求。同樣，卡爾蔡司醫療技術公司於 2024 年 12 月發布的 2023/24 年度報告顯示，其眼科戰略業務部門創造了 15.9 億歐元的收入，反映出該公司在全球範圍內持續投資高科技眼科解決方案。

此外，眼科疾病和視網膜疾病盛行率的上升是第二個關鍵促進因素，從根本上擴大了需要手術干預的患者群體。隨著世界人口老化，老齡化黃斑部病變和視網膜剝離等與老齡化相關的疾病負擔日益加重，因此需要更頻繁地進行玻璃體視網膜手術以防止不可逆的視力喪失。這些人口趨勢導致手術病例增加，而手術病例的增加在很大程度上不受經濟週期的影響，因為這些干預措施通常是緊急且必要的。近期發布的國家健康數據顯示了這種疾病負擔的規模。根據美國疾病管制與預防中心 (CDC) 視覺和眼健康監測系統 2024 年 5 月的更新數據，估計約有 1,980 萬美國人患有老齡化黃斑部病變，而且該疾病經常進展到需要複雜手術治療的階段。這種盛行率的上升直接促使人們更多地使用玻璃體手術設備來處理可能導致患者視力喪失的併發症。

市場挑戰

玻璃體手術系統和手術流程的高成本是全球玻璃體手術器械市場的主要阻礙因素。這些手術平台需要對主機和視覺化設備進行大量資本投入，同時也需要持續支付切割器和雷射探針等一次性耗材的費用。在醫療預算有限的發展中地區，這種經濟負擔使得醫療機構難以購買必要的技術，從而限制了患者獲得必要的視網膜治療，並直接縮小了器械製造商的潛在市場規模。

醫療機構報銷率的下降加劇了這項經濟挑戰，並抑制了新興技術的應用。根據美國視網膜專家協會統計，截至2024年，經通膨調整後的聯邦醫療保險（Medicare）玻璃體切除手術報銷額在過去十年中下降了約27%。手術設備的高昂投入成本與手術收入的下降之間日益擴大的差距，使許多醫院的財務狀況難以為繼。因此，醫療機構往往被迫推遲設備升級或限制服務擴張，從而有效地減緩了市場的整體成長速度。

市場趨勢

視網膜手術向門診手術中心（ASC）的轉移正在從根本上改變玻璃體手術的服務模式。這項轉變的驅動力在於提高營運效率和控制成本，因為對於常規玻璃體視網膜病例而言，門診手術中心比傳統醫院門診部更有效率。監管機構和支付方也透過擴大報銷範圍來鼓勵這一轉變，使得諸如脈衝平面玻璃體切除手術等複雜手術能夠在這些成本更低的場所安全進行。大型醫療果凍的表現表明，這種模式具有財務擴充性。在2025年11月發布的「2025會計年度第三季財報電話會議」中，Surgery Partners報告稱其合併收入淨額總額為8.215億美元，並明確表示其持續成長歸功於其醫療機構網路內包括眼科在內的高級急性外科服務項目的擴張。

同時，抬頭式3D數位視覺化平台的引進正在改變手術室環境，以高清數位顯示器取代類比光學顯微鏡。這項技術解決了外科醫生在長時間視網膜修復手術中面臨的人體工學難題，使他們能夠以「抬頭」姿勢進行操作，從而減輕頸部壓力和疲勞。此外，這些數位系統能夠降低照明強度，最大限度地減少對患者視網膜的光毒性風險，同時提高景深和色彩對比度，並實現精準的膜剝離。這些先進外科產品線的商業性成功也反映在近期的產業財務表現。根據博士倫公司於2025年2月發布的「2024年第四季及全年」財務報告，該公司外科部門的季度收入為2.31億美元，年增13%。這證實了市場對現代眼科技術和整合式手術室解決方案日益成長的需求。

目錄

第1章概述

第2章調查方法

第3章執行摘要

第4章：客戶評價

第5章 全球玻璃體手術器械市場展望

• 市場規模及預測
  • 按金額
• 市佔率及預測
  • 依產品分類（玻璃體切除裝置、玻璃體切除包、光凝雷射、照明裝置）
  • 依應用領域（糖尿病視網膜病變、視網膜剝離、黃斑裂孔、玻璃體出血等）
  • 依最終用途（醫院、眼科診所、門診手術中心）
  • 按地區
  • 按公司（2025 年）
• 市場地圖

第6章：北美玻璃體手術器械市場展望

• 市場規模及預測
• 市佔率及預測
• 北美洲：國家分析
  • 美國
  • 加拿大
  • 墨西哥

第7章：歐洲玻璃體手術器械市場展望

• 市場規模及預測
• 市佔率及預測
• 歐洲：國家分析
  • 德國
  • 法國
  • 英國
  • 義大利
  • 西班牙

8. 亞太地區玻璃體手術器械市場展望

• 市場規模及預測
• 市佔率及預測
• 亞太地區：國家分析
  • 中國
  • 印度
  • 日本
  • 韓國
  • 澳洲

第9章：中東和非洲玻璃體手術器械市場展望

• 市場規模及預測
• 市佔率及預測
• 中東和非洲：國家分析
  • 沙烏地阿拉伯
  • 阿拉伯聯合大公國
  • 南非

第10章：南美洲玻璃體手術器械市場展望

• 市場規模及預測
• 市佔率及預測
• 南美洲：國家分析
  • 巴西
  • 哥倫比亞
  • 阿根廷

第11章 市場動態

• 促進要素
• 任務

第12章 市場趨勢與發展

• 併購
• 產品發布
• 最新進展

第13章 全球玻璃體手術器械市場：SWOT分析

第14章：波特五力分析

• 產業競爭
• 新進入者的可能性
• 供應商電力
• 顧客權力
• 替代品的威脅

第15章 競爭格局

• Alcon Inc.
• Bausch+Lomb.
• BVI
• NIDEK CO., LTD.
• Johnson & Johnson Vision Care, Inc.
• Blink Medical
• Topcon Corporation
• Carl Zeiss Meditec AG
• HOYA Medical Singapore Pte. Ltd
• Leica Microsystems

第16章 策略建議

第17章：關於研究公司及免責聲明

The Global Vitrectomy Devices Market is projected to expand from USD 1.72 Billion in 2025 to USD 2.48 Billion by 2031, reflecting a CAGR of 6.29%. This market consists of specialized surgical instruments and systems used to extract vitreous humor for the treatment of retinal conditions such as macular holes and retinal detachment. The primary factors driving growth include the rising prevalence of ocular diseases and an aging global population. A crucial element accelerating this demand is the increasing incidence of diabetes, which significantly raises the risk of diabetic retinopathy. As noted by the International Diabetes Federation, approximately 589 million adults worldwide were living with diabetes in 2024, creating a substantial patient base that requires effective vitreoretinal interventions and sustains the demand for these surgical devices.

However, a major obstacle hindering market growth is the substantial cost associated with advanced vitrectomy systems and the surgical procedures themselves. This financial barrier restricts access to essential eye care in developing regions where healthcare budgets are limited. Furthermore, the shortage of skilled retinal surgeons in these areas exacerbates the difficulty of providing timely treatment, presenting a significant impediment to the widespread adoption of vitreoretinal technologies.

Market Driver

Technological innovations in vitrectomy instrumentation are significantly driving market growth by improving surgical precision and patient outcomes. Modern vitrectomy systems now incorporate features such as higher cut rates, enhanced fluidics, and smaller gauge instruments, which collectively decrease retinal traction and minimize post-operative complications. This cycle of innovation fuels consistent demand for equipment replacement and the adoption of premium consumables as hospitals transition to safer, more efficient platforms. The strong market reception for these advanced technologies is evident in the financial results of key industry players. For instance, Alcon reported in its 'Fourth Quarter and Full Year 2023 Results' in February 2024 that surgical consumables net sales reached $688 million for the quarter, attributing this growth to the demand for vitreoretinal products. Similarly, Carl Zeiss Meditec's 'Annual Report 2023/24' from December 2024 indicated that its Ophthalmology Strategic Business Unit generated €1.59 billion in revenue, reflecting ongoing global investment in high-tech ophthalmic solutions.

Additionally, the rising prevalence of ocular and retinal disorders serves as a second critical driver, fundamentally expanding the patient population requiring surgical intervention. As the global population ages, the burden of age-related conditions like macular degeneration and retinal detachment increases, necessitating more frequent vitreoretinal procedures to prevent irreversible vision loss. This demographic trend creates a growing volume of surgical cases that is largely independent of economic cycles, as these interventions are often urgent and essential. The scale of this disease burden is illustrated by recent national health data; according to the Centers for Disease Control and Prevention's 'Vision and Eye Health Surveillance System' update in May 2024, approximately 19.8 million Americans are estimated to be living with age-related macular degeneration, a condition that frequently progresses to stages requiring complex surgical management. This escalating prevalence directly supports the increasing utilization of vitrectomy devices to manage sight-threatening complications.

Market Challenge

The high cost associated with vitrectomy systems and surgical procedures constitutes a primary restraint on the Global Vitrectomy Devices Market. These surgical platforms require substantial capital investment for consoles and visualization equipment, alongside recurring expenses for single-use disposables such as cutters and laser probes. In developing regions with restricted healthcare budgets, this financial burden prevents medical facilities from procuring necessary technology, thereby limiting patient access to essential retinal care and directly reducing the addressable market size for device manufacturers.

This economic challenge is further intensified by declining compensation rates for providers, which disincentivizes the adoption of modern technologies. According to the American Society of Retina Specialists, in 2024, inflation-adjusted Medicare reimbursements for pars plana vitrectomy procedures decreased by approximately 27% over the preceding decade. This widening gap between the high acquisition cost of surgical devices and the diminishing revenue for procedures creates a fiscally unsustainable environment for many hospitals. Consequently, healthcare providers are often forced to delay equipment upgrades or limit service expansion, effectively dampening the overall growth trajectory of the market.

Market Trends

The migration of retinal procedures to Ambulatory Surgical Centers (ASCs) is fundamentally reshaping the service delivery model for vitrectomy surgeries. This shift is driven by the need for operational efficiency and cost containment, as ASCs offer a streamlined alternative to traditional hospital outpatient departments for routine vitreoretinal cases. Regulatory bodies and payers are increasingly incentivizing this transition through expanded reimbursement codes, allowing complex procedures such as pars plana vitrectomy to be performed safely in these lower-cost settings. The financial scalability of this model is evident in the performance of major facility operators. According to Surgery Partners, November 2025, in the 'Q3 2025 Earnings Call', the company reported total consolidated net revenue of $821.5 million, explicitly attributing part of its sustained growth to the expansion of high-acuity surgical service lines, including ophthalmology, within its facility network.

Simultaneously, the integration of Heads-Up 3D Digital Visualization Platforms is transforming the surgical cockpit by replacing analog optical microscopes with high-definition digital displays. This technology addresses the ergonomic challenges faced by surgeons during lengthy retinal repairs, allowing them to operate in a "heads-up" position that reduces neck strain and fatigue. Furthermore, these digital systems enable reduced illumination levels, which minimizes the risk of phototoxicity to the patient's retina while enhancing depth of field and color contrast for precise membrane peeling. The commercial traction of such advanced surgical portfolios is reflected in recent industry financial results. According to Bausch + Lomb, February 2025, in the 'Fourth Quarter and Full-Year 2024 Results', the Surgical segment generated revenue of $231 million for the quarter, representing a 13% increase that underscores the growing market demand for modern ophthalmic technologies and integrated operating room solutions.

Key Market Players

• Alcon Inc.
• Bausch + Lomb.
• BVI
• NIDEK CO., LTD.
• Johnson & Johnson Vision Care, Inc.
• Blink Medical
• Topcon Corporation
• Carl Zeiss Meditec AG
• HOYA Medical Singapore Pte. Ltd
• Leica Microsystems

Report Scope

In this report, the Global Vitrectomy Devices Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Vitrectomy Devices Market, By Product

• Vitrectomy Machine
• Vitrectomy Packs
• Photocoagulation Lasers
• Illumination Devices

Vitrectomy Devices Market, By Application

• Diabetic Retinopathy
• Retinal Detachment
• Macular Hole
• Vitreous Hemorrhage
• Others

Vitrectomy Devices Market, By End use

• Hospitals
• Ophthalmic Clinics
• Ambulatory Surgical Centers

Vitrectomy Devices Market, By Region

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Vitrectomy Devices Market.

Available Customizations:

Global Vitrectomy Devices Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Vitrectomy Devices Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Product (Vitrectomy Machine, Vitrectomy Packs, Photocoagulation Lasers, Illumination Devices)
  • 5.2.2. By Application (Diabetic Retinopathy, Retinal Detachment, Macular Hole, Vitreous Hemorrhage, Others)
  • 5.2.3. By End use (Hospitals, Ophthalmic Clinics, Ambulatory Surgical Centers)
  • 5.2.4. By Region
  • 5.2.5. By Company (2025)
• 5.3. Market Map

6. North America Vitrectomy Devices Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Product
  • 6.2.2. By Application
  • 6.2.3. By End use
  • 6.2.4. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Vitrectomy Devices Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Product
      • 6.3.1.2.2. By Application
      • 6.3.1.2.3. By End use
  • 6.3.2. Canada Vitrectomy Devices Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Product
      • 6.3.2.2.2. By Application
      • 6.3.2.2.3. By End use
  • 6.3.3. Mexico Vitrectomy Devices Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Product
      • 6.3.3.2.2. By Application
      • 6.3.3.2.3. By End use

7. Europe Vitrectomy Devices Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Product
  • 7.2.2. By Application
  • 7.2.3. By End use
  • 7.2.4. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany Vitrectomy Devices Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Product
      • 7.3.1.2.2. By Application
      • 7.3.1.2.3. By End use
  • 7.3.2. France Vitrectomy Devices Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Product
      • 7.3.2.2.2. By Application
      • 7.3.2.2.3. By End use
  • 7.3.3. United Kingdom Vitrectomy Devices Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Product
      • 7.3.3.2.2. By Application
      • 7.3.3.2.3. By End use
  • 7.3.4. Italy Vitrectomy Devices Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Product
      • 7.3.4.2.2. By Application
      • 7.3.4.2.3. By End use
  • 7.3.5. Spain Vitrectomy Devices Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Product
      • 7.3.5.2.2. By Application
      • 7.3.5.2.3. By End use

8. Asia Pacific Vitrectomy Devices Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Product
  • 8.2.2. By Application
  • 8.2.3. By End use
  • 8.2.4. By Country
• 8.3. Asia Pacific: Country Analysis
  • 8.3.1. China Vitrectomy Devices Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Product
      • 8.3.1.2.2. By Application
      • 8.3.1.2.3. By End use
  • 8.3.2. India Vitrectomy Devices Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Product
      • 8.3.2.2.2. By Application
      • 8.3.2.2.3. By End use
  • 8.3.3. Japan Vitrectomy Devices Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Product
      • 8.3.3.2.2. By Application
      • 8.3.3.2.3. By End use
  • 8.3.4. South Korea Vitrectomy Devices Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Product
      • 8.3.4.2.2. By Application
      • 8.3.4.2.3. By End use
  • 8.3.5. Australia Vitrectomy Devices Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Product
      • 8.3.5.2.2. By Application
      • 8.3.5.2.3. By End use

9. Middle East & Africa Vitrectomy Devices Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Product
  • 9.2.2. By Application
  • 9.2.3. By End use
  • 9.2.4. By Country
• 9.3. Middle East & Africa: Country Analysis
  • 9.3.1. Saudi Arabia Vitrectomy Devices Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Product
      • 9.3.1.2.2. By Application
      • 9.3.1.2.3. By End use
  • 9.3.2. UAE Vitrectomy Devices Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Product
      • 9.3.2.2.2. By Application
      • 9.3.2.2.3. By End use
  • 9.3.3. South Africa Vitrectomy Devices Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Product
      • 9.3.3.2.2. By Application
      • 9.3.3.2.3. By End use

10. South America Vitrectomy Devices Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Product
  • 10.2.2. By Application
  • 10.2.3. By End use
  • 10.2.4. By Country
• 10.3. South America: Country Analysis
  • 10.3.1. Brazil Vitrectomy Devices Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Product
      • 10.3.1.2.2. By Application
      • 10.3.1.2.3. By End use
  • 10.3.2. Colombia Vitrectomy Devices Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Product
      • 10.3.2.2.2. By Application
      • 10.3.2.2.3. By End use
  • 10.3.3. Argentina Vitrectomy Devices Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Product
      • 10.3.3.2.2. By Application
      • 10.3.3.2.3. By End use

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Merger & Acquisition (If Any)
• 12.2. Product Launches (If Any)
• 12.3. Recent Developments

13. Global Vitrectomy Devices Market: SWOT Analysis

14. Porter's Five Forces Analysis

• 14.1. Competition in the Industry
• 14.2. Potential of New Entrants
• 14.3. Power of Suppliers
• 14.4. Power of Customers
• 14.5. Threat of Substitute Products

15. Competitive Landscape

• 15.1. Alcon Inc.
  • 15.1.1. Business Overview
  • 15.1.2. Products & Services
  • 15.1.3. Recent Developments
  • 15.1.4. Key Personnel
  • 15.1.5. SWOT Analysis
• 15.2. Bausch + Lomb.
• 15.3. BVI
• 15.4. NIDEK CO., LTD.
• 15.5. Johnson & Johnson Vision Care, Inc.
• 15.6. Blink Medical
• 15.7. Topcon Corporation
• 15.8. Carl Zeiss Meditec AG
• 15.9. HOYA Medical Singapore Pte. Ltd
• 15.10. Leica Microsystems

16. Strategic Recommendations

17. About Us & Disclaimer